Richard van den Broek

Insider Reports History

Entity
Individual
Location
73 Arch Street, 1 St Floor, Greenwich, CT
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard van den Broek:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pulse Biosciences, Inc. Director Stock Option (right to buy) 11.6K Jun 6, 2024 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 0 May 19, 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 May 19, 2023 Direct

Insider Reports Filed by Richard van den Broek

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLSE Pulse Biosciences, Inc. Jun 6, 2024 2 $0 4 Jun 24, 2024 Director
PLSE Pulse Biosciences, Inc. May 25, 2023 2 $0 4 Jun 6, 2023 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2023 2 $0 4 May 19, 2023 Director
PLSE Pulse Biosciences, Inc. May 19, 2022 2 $0 4 May 23, 2022 Director
PHASQ PhaseBio Pharmaceuticals Inc May 19, 2022 2 $0 4 May 20, 2022 Director
PHASQ PhaseBio Pharmaceuticals Inc Jun 3, 2021 1 $0 4 Jun 4, 2021 Director
PLSE Pulse Biosciences, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director